U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 78

1.
Etoposide, an anticancer drug involved in therapy-related secondary leukemia: Enzymes at play
Wenchao Zhang, Panhong Gou, Jean-Marie Dupret, Christine Chomienne, Fernando Rodrigues-Lima
Transl Oncol. 2021 Oct; 14(10): 101169. Published online 2021 Jul 6. doi: 10.1016/j.tranon.2021.101169
PMCID:
PMC8273223
AbstractArticlePDF–1.7M
2.
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)
Anna L. Brown, Christopher N. Hahn, Hamish S. Scott
Blood. 2020 Jul 2; 136(1): 24–35. Prepublished online 2020 May 19. doi: 10.1182/blood.2019000937
PMCID:
PMC7332898
AbstractArticle
3.
Genetics of progression from MDS to secondary leukemia
Andrew J. Menssen, Matthew J. Walter
Blood. 2020 Jul 2; 136(1): 50–60. Prepublished online 2020 May 19. doi: 10.1182/blood.2019000942
PMCID:
PMC7332895
AbstractArticle
4.
REDUCED RISK OF SECONDARY LEUKEMIA WITH FEWER CYCLES OF DOSE-INTENSIVE INDUCTION CHEMOTHERAPY IN PATIENTS WITH NEUROBLASTOMA
Brian H. Kushner, Kim Kramer, Shakeel Modak, Li-Xuan Qin, Karima Yataghena, Suresh C. Jhanwar, Nai-Kong V. Cheung
Pediatr Blood Cancer. Author manuscript; available in PMC 2014 Jul 2.
Published in final edited form as: Pediatr Blood Cancer. 2009 Jul; 53(1): 17–22. doi: 10.1002/pbc.21931
PMCID:
PMC4079040
AbstractArticlePDF–356K
5.
A Case of Secondary Leukemia Subsequent to Myelodysplastic Syndromes Successfully Treated with Azacitidine
Takahiro Kumode, Ayano Fukui, Go Eguchi, Terufumi Yamaguchi, Yasuhiro Maeda
Case Rep Med. 2014; 2014: 793928. Published online 2014 Mar 31. doi: 10.1155/2014/793928
PMCID:
PMC3988727
AbstractArticlePDF–581K
6.
Disrupting BCR-ABL in Combination with Secondary Leukemia-Specific Pathways in CML Cells Leads to Enhanced Apoptosis and Decreased Proliferation
David W. Woessner, Carol S. Lim
Mol Pharm. Author manuscript; available in PMC 2014 Jan 7.
Published in final edited form as: Mol Pharm. 2013 Jan 7; 10(1): 270–277. Published online 2012 Dec 18. doi: 10.1021/mp300405n
PMCID:
PMC3604893
AbstractArticlePDF–3.3M
7.
Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials
Michael Zach Koontz, Sandra J. Horning, Raymond Balise, Peter L. Greenberg, Saul A. Rosenberg, Richard T. Hoppe, Ranjana H. Advani
J Clin Oncol. 2013 Feb 10; 31(5): 592–598. Published online 2013 Jan 7. doi: 10.1200/JCO.2012.44.5791
PMCID:
PMC3565182
AbstractArticlePDF–208K
8.
Secondary Leukemia in a non-Hodgkin's Lymphoma Patient Presenting as Myeloid Sarcoma of the Breast
Vincenzo Pitini, Carmela Arrigo, Maria Grazia Sauta, Giuseppe Altavilla
Case Rep Hematol. 2011; 2011: 914613. Published online 2011 Jul 12. doi: 10.1155/2011/914613
PMCID:
PMC3420753
AbstractArticlePDF–2.1M
9.
Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor
Sachiko Ezoe
Int J Environ Res Public Health. 2012 Jul; 9(7): 2444–2453. Published online 2012 Jul 10. doi: 10.3390/ijerph9072444
PMCID:
PMC3407914
AbstractArticlePDF–112K
10.
A quantification method of somatic mutations in normal tissues and their accumulation in pediatric patients with chemotherapy
Sho Ueda, Satoshi Yamashita, Miho Nakajima, Tadashi Kumamoto, Chitose Ogawa, Yu-yu Liu, Harumi Yamada, Emi Kubo, Naoko Hattori, Hideyuki Takeshima, Mika Wakabayashi, Naoko Iida, Yuichi Shiraishi, Masayuki Noguchi, Yukio Sato, Toshikazu Ushijima
Proc Natl Acad Sci U S A. 2022 Aug 2; 119(31): e2123241119. Published online 2022 Jul 27. doi: 10.1073/pnas.2123241119
PMCID:
PMC9351471
AbstractArticlePDF–1.2M
11.
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms
Giuseppe G. Loscocco, Giacomo Coltro, Paola Guglielmelli, Alessandro M. Vannucchi
Cells. 2021 Aug; 10(8): 1962. Published online 2021 Aug 2. doi: 10.3390/cells10081962
PMCID:
PMC8391705
AbstractArticlePDF–415K
12.
Hematologic indices in individuals with pathogenic germline DICER1 variants
Lauren M. Vasta, Nicholas E. Khan, Cecilia P. Higgs, Laura A. Harney, Ann G. Carr, Anne K. Harris, Kris Ann P. Schultz, Mary L. McMaster, Douglas R. Stewart
Blood Adv. 2021 Jan 12; 5(1): 216–223. Published online 2021 Jan 7. doi: 10.1182/bloodadvances.2020002651
PMCID:
PMC7805337
AbstractArticlePDF–883K
13.
Ataxia telangiectasia mutated‐dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor
Hiroyuki Tamaichi, Masaki Sato, Andrew C. G. Porter, Toshiaki Shimizu, Shuki Mizutani, Masatoshi Takagi
Cancer Sci. 2013 Feb; 104(2): 178–184. Published online 2013 Jan 13. doi: 10.1111/cas.12067
PMCID:
PMC7657118
AbstractArticlePDF–503K
14.
Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
Alexandra Higgins, Mithun Vinod Shah
Genes (Basel) 2020 Jul; 11(7): 749. Published online 2020 Jul 6. doi: 10.3390/genes11070749
PMCID:
PMC7397259
AbstractArticlePDF–759K
15.
Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
Naval Daver, Hagop Kantarjian, Guillermo Garcia-Manero, Elias Jabbour, Gautam Borthakur, Mark Brandt, Sherry Pierce, Kenneth Vaughan, Jing Ning, Graciela M. Nogueras González, Keyur Patel, Jeffery Jorgensen, Naveen Pemmaraju, Tapan Kadia, Marina Konopleva, Michael Andreeff, Courtney DiNardo, Jorge Cortes, Renee Ward, Adam Craig, Farhad Ravandi
Haematologica. 2017 Oct; 102(10): 1709–1717. Prepublished online 2017 Jul 20. doi: 10.3324/haematol.2017.168732
PMCID:
PMC5622855
AbstractArticlePDF–590K
16.
Clonal evolution in therapy-related neoplasms
Emiliano Fabiani, Giulia Falconi, Luana Fianchi, Marianna Criscuolo, Tiziana Ottone, Laura Cicconi, Stefan Hohaus, Simona Sica, Massimiliano Postorino, Antonino Neri, Marta Lionetti, Giuseppe Leone, Francesco Lo-Coco, Maria Teresa Voso
Oncotarget. 2017 Feb 14; 8(7): 12031–12040. Published online 2017 Jan 5. doi: 10.18632/oncotarget.14509
PMCID:
PMC5355323
AbstractArticlePDF–2.3M
17.
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors
Daniela Damiani, Mario Tiribelli, Donatella Raspadori, Santina Sirianni, Alessia Meneghel, Margherita Cavalllin, Angela Michelutti, Eleonora Toffoletti, Antonella Geromin, Erica Simeone, Monica Bocchia, Renato Fanin
Oncotarget. 2015 Oct 6; 6(30): 30212–30221. Published online 2015 Aug 18. doi: 10.18632/oncotarget.4901
PMCID:
PMC4745791
AbstractArticlePDF–1.9M
18.
P53-Based Strategy for Protection of Bone Marrow from Y-90 Ibritumomab Tiuxetan
Hang Su, Suthakar Ganapathy, Xiaolei Li, Zhi-Min Yuan, Chul S. Ha
Int J Radiat Oncol Biol Phys. Author manuscript; available in PMC 2016 Aug 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2015 Aug 1; 92(5): 1116–1122. Published online 2015 Apr 8. doi: 10.1016/j.ijrobp.2015.04.003
PMCID:
PMC4509863
AbstractArticlePDF–624K
19.
Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation
Hamza Celik, Cates Mallaney, Alok Kothari, Elizabeth L. Ostrander, Elizabeth Eultgen, Andrew Martens, Christopher A. Miller, Jasreet Hundal, Jeffery M. Klco, Grant A. Challen
Blood. 2015 Jan 22; 125(4): 619–628. Prepublished online 2014 Nov 21. doi: 10.1182/blood-2014-08-594564
PMCID:
PMC4304107
AbstractArticle
20.
S-1 induced secondary acute erythroid leukemia with a chromosome inv(12)(p13;q13)
Kensuke Matsumoto, Akira Kitanaka, Makiko Uemura, Fusako Waki, Tetsuya Fukumoto, Hiroaki Ohnishi, Yoshitsugu Kubota, Toshihiko Ishida
World J Gastroenterol. 2011 Nov 7; 17(41): 4632–4634. Published online 2011 Nov 7. doi: 10.3748/wjg.v17.i41.4632
PMCID:
PMC3225100
AbstractArticlePDF–545K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center
-